EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Computational Elucidation of the Antidiabetic Mechanism of Catechin and Apigenin via Network Pharmacology and Molecular Docking

Shaikh Faizan, Shaikh Asif Ayyub, Shaikh Mehmood Dawood

Journal of Innovations in Pharmaceutical and Biological Sciences · 2026 · 13 (01) · 03-13

DOI: 10.56511/jipbs.2026.13102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innovations in Pharmaceutical and Biological Sciences, 2026. Verfasst von Shaikh Faizan und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin resistance, poor glucose homeostasis, oxidative stress, inflammation, and pancreatic β-cell dysfunction are the hallmarks of Type 2 Diabetes Mellitus (T2DM), a chronic metabolic disease. The search for safer multitarget therapeutic agents made from natural products is necessary due to the rising incidence of type 2 diabetes and the drawbacks of traditional antidiabetic treatments. Apigenin and catechin have anti-inflammatory, antihyperglycemic, insulin-sensitizing, and antioxidant qualities. The current study examined the therapeutic mechanisms of apigenin and catechin against type 2 diabetes using integrated network pharmacology and molecular docking techniques. Protein-protein interaction (PPI), Gene Ontology (GO), and KEGG pathway enrichment studies were performed after T2DM-associated genes and potential phytochemical targets were found using publically accessible databases. Important hub genes linked to insulin signaling and glucose metabolism were found by network analysis, including PIK3R1, ESR1, AKT1, EGFR, and PTK2. PI3K-Akt and endocrine resistance pathways were significantly enriched, according to KEGG analysis. Catechin has a strong binding affinity for PIK3R1 (-6.1 kcal/mol) and AKT1 (-6.4 kcal/mol) according to molecular docking, whereas Apigenin had docking scores of -5.7 and -6.3 kcal/mol, respectively, when compared to Metformin. These results offer a scientific foundation for additional experimental confirmation and imply that catechin and apigenin may have antidiabetic effects through multitarget regulation.

Zitieren

APA

Faizan, S., Ayyub, S. A., & Dawood, S. M. (2026). Computational Elucidation of the Antidiabetic Mechanism of Catechin and Apigenin via Network Pharmacology and Molecular Docking. Journal of Innovations in Pharmaceutical and Biological Sciences, 13(01), 03-13. https://doi.org/10.56511/jipbs.2026.13102

Vancouver

Faizan S, Ayyub SA, Dawood SM. Computational Elucidation of the Antidiabetic Mechanism of Catechin and Apigenin via Network Pharmacology and Molecular Docking. Journal of Innovations in Pharmaceutical and Biological Sciences. 2026;13(01):03-13. doi:10.56511/jipbs.2026.13102

BibTeX
@article{Faizan2026,
  author = {Faizan, Shaikh and Ayyub, Shaikh Asif and Dawood, Shaikh Mehmood},
  title = {Computational Elucidation of the Antidiabetic Mechanism of Catechin and Apigenin via Network Pharmacology and Molecular Docking},
  journal = {Journal of Innovations in Pharmaceutical and Biological Sciences},
  year = {2026},
  volume = {13},
  number = {01},
  pages = {03--13},
  doi = {10.56511/jipbs.2026.13102}
}
Kostenlos starten →